Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C4H9Cl2N.ClH |
| Molecular Weight | 178.488 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.ClCCNCCCl
InChI
InChIKey=YMDZDFSUDFLGMX-UHFFFAOYSA-N
InChI=1S/C4H9Cl2N.ClH/c5-1-3-7-4-2-6;/h7H,1-4H2;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C4H9Cl2N |
| Molecular Weight | 142.027 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Bis[2-((4,6-dimethyl-pyrimidin-2-yl){2-[(4,6-dimethyl-pyrimidin-2-yl)sulfan-yl]eth-yl}amino)-eth-yl] disulfide. | 2010-09-08 |
|
| 3-[2-(1,3-Benzothia-zol-2-ylsulfan-yl)eth-yl]-1,3-oxazolidin-2-one. | 2010-09-04 |
|
| Childhood physical abnormalities following paternal exposure to sulfur mustard gas in Iran: a case-control study. | 2010-07-14 |
|
| 3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one. | 2010-04-10 |
|
| 6-Bromo-1-[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-imidazo[4,5-b]pyridin-2(3H)-one. | 2010-01-27 |
|
| 3-[2-(2,3-Dioxoindolin-1-yl)eth-yl]-1,3-oxazolidin-2-one. | 2010-01-27 |
|
| The role of funding and policies on innovation in cancer drug development. | 2010 |
|
| N,N,N,N-Tetra-kis(2-chloro-ethyl)-3,4-dimethyl-thio-phene-2,5-dicarboxamide. | 2009-12-12 |
|
| Synthesis and cytotoxic activity of novel amidine analogues of bis(2-chloroethyl)amine. | 2009-08 |
|
| New di-(beta-chloroethyl)-alpha-amides on N-(meta-acylamino-benzoyl)- D,L-aminoacid supports with antitumoral activity. | 2008-01-28 |
|
| N-terminal bis-(2-chloroethyl)amino and fluorosulphonyl analogues of calcitonin gene-related peptide(8-37): irreversible antagonists at calcitonin gene-related peptide receptors. | 2007-09 |
|
| Combined effect of bis-beta-chloroethylamine estrogen derivatives and doxorubicin on proliferation of sensitive and resistant MCF-7 cells. | 2007-03 |
|
| Synthesis of diazahexathia-24-crown-8 derivatives and structures of Ag+ complexes. | 2006-05-14 |
|
| Evaluation of fluorenhymustine as a rationally designed novel anticancer agent. | 2005-12 |
|
| Synthesis, in vitro and in vivo evaluation of a delivery system for targeting anticancer drugs to the brain. | 2003-10 |
|
| Binding of bis-beta-chloroethylamine derivatives of synthetic estrogens to proteins: dependence on the chemical structure. | 2002-12 |
|
| A novel kind of antitumour drugs using sulfonamide as parent compound. | 2002-01-05 |
|
| Synthesis and metal-ion binding properties of monoazathiacrown ethers. | 2001-10-19 |
|
| Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies. | 2001-08-16 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:56:30 GMT 2025
by
admin
on
Mon Mar 31 21:56:30 GMT 2025
|
| Record UNII |
LY407360DG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
212-479-5
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY | |||
|
DTXSID3052567
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY | |||
|
10873
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY | |||
|
821-48-7
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY | |||
|
300000052916
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY | |||
|
13186
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY | |||
|
1157013
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY | |||
|
LY407360DG
Created by
admin on Mon Mar 31 21:56:30 GMT 2025 , Edited by admin on Mon Mar 31 21:56:30 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|